Loading stock data...

Panacea Biotec Limited

NSE: PANACEABIO BSE: PANACEABIO

NSE
336.25 2.00 (0.60%)

Prev Close

334.25

Open Price

328.5

Volume

60,105

Today Low / High

328.5 / 343

52 WK Low / High

281.1 / 581.9

Range

319 - 353

BSE
335.50 0.85 (0.25%)

Prev Close

334.65

Open Price

334.65

Volume

527

Today Low / High

333 / 341.55

52 WK Low / High

282.15 / 581

Range

319 - 352

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 336.25 (target range: 319 - 353), reflecting a change of 2 (0.59835%). On the BSE, it is listed at 335.5 (target range: 319 - 352), showing a change of 0.85 (0.254%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.

20 Feb 346.05 -1.31%
19 Feb 356.80 -3.03%
18 Feb 360.00 -1.99%
17 Feb 347.05 4.38%
16 Feb 348.95 -0.60%
13 Feb 355.70 -1.59%
12 Feb 359.90 -0.74%
11 Feb 376.55 -5.83%
10 Feb 374.00 0.12%
09 Feb 367.00 0.98%
06 Feb 367.90 -1.29%
05 Feb 380.95 -2.35%
04 Feb 375.00 1.57%
03 Feb 374.00 -0.95%
02 Feb 368.05 -0.18%
01 Feb 370.45 -0.94%
30 Jan 359.00 3.89%
29 Jan 378.70 -4.44%
28 Jan 354.70 5.24%

Panacea Biotec Limited Graph

Panacea Biotec Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Panacea Biotec Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 336.25, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 335.50 338.86 304.97 - 372.74
342.21 273.77 - 410.65
345.57 241.90 - 449.23
Bearish Scenario 335.50 332.15 298.93 - 365.36
328.79 263.03 - 394.55
325.44 227.80 - 423.07

Overview of Panacea Biotec Limited

ISIN

INE922B01023

Industry

Biotechnology

Vol.Avg

1,103,323

Market Cap

20,834,441,252

Last Dividend

0

Official Website

Visit Website

IPO Date

2002-07-01

DCF Diff

1,085.75

DCF

-541

Financial Ratios Every Investor Needs

Stock Dividend of PANACEABIO

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2011-09-19 September 19, 11 0.75 0.75 2011-09-20 2011-10-10 2011-05-13
2010-09-16 September 16, 10 0.25 0.25 2010-09-18 2010-10-25 2010-05-07
2008-09-19 September 19, 08 1 1 2008-09-23 2008-10-26 2008-06-26
2007-09-21 September 21, 07 1 1 2007-09-25 2007-10-28 2007-06-14
2006-09-22 September 22, 06 1 1 2006-09-26 2006-10-11 2006-05-22

Stock Rating Details for PANACEABIO

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 559.09 Cr 199.54 Cr 359.55 Cr 0.6431 42.84 Cr 177.83 Cr -60.72 Cr -8.37 Cr -1.37 30.74 Cr -0.0150
2024-03-31 551.93 Cr 268.95 Cr 44.65 Cr 0.0809 36.87 Cr 29.53 Cr -13.81 Cr -1.17 Cr -0.19 41.54 Cr -0.0021
2023-03-31 456.92 Cr 278.76 Cr 178.16 Cr 0.3899 32.84 Cr 15.84 Cr -105.65 Cr -33.24 Cr -5.43 56.37 Cr -0.0727
2022-03-31 659.22 Cr 317.67 Cr 341.56 Cr 0.5181 10.51 Cr 27.67 Cr -51.82 Cr 1,078.32 Cr 176.05 1,673.97 Cr 1.6357
2021-03-31 617.65 Cr 204.63 Cr 413.02 Cr 0.6687 39.02 Cr 27.47 Cr 32.79 Cr -147.70 Cr -24.11 86.52 Cr -0.2391

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 82.13 Cr 1,289.75 Cr 459.13 Cr 834.7900 Cr 22.21 Cr -59.92 Cr 213.67 Cr 636.90 Cr 0.00 Cr 10.85 Cr 18.86 Cr 366.9900 Cr
2024-03-31 47.17 Cr 1,240.67 Cr 402.45 Cr 842.0460 Cr 20.99 Cr -26.18 Cr 177.94 Cr 634.76 Cr 0.00 Cr 21.85 Cr 13.65 Cr 308.8320 Cr
2023-03-31 39.85 Cr 1,271.17 Cr 431.05 Cr 843.6030 Cr 20.22 Cr -19.63 Cr 202.09 Cr 623.34 Cr 0.00 Cr 32.14 Cr -168.24 Cr 331.8310 Cr
2022-03-31 50.35 Cr 1,758.87 Cr 885.21 Cr 876.6360 Cr 34.16 Cr -16.20 Cr 212.72 Cr 627.67 Cr 0.00 Cr 43.13 Cr -417.62 Cr 776.3670 Cr
2021-03-31 52.08 Cr 1,177.53 Cr 1,409.23 Cr -228.6930 Cr 819.53 Cr 767.45 Cr 174.14 Cr 627.89 Cr 0.00 Cr 2.91 Cr -37.69 Cr 449.0910 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -27.3700 Cr 64.9800 Cr -2.6600 Cr -77.6800 Cr 34.9600 Cr 82.1300 Cr -50.3100 Cr -7.9500 Cr 0.0000 Cr 0.0000 Cr -35.7400 Cr
2024-03-31 -0.1000 Cr 10.2270 Cr -2.8080 Cr -77.8180 Cr 7.3220 Cr 47.1740 Cr -77.7180 Cr -1.1730 Cr -0.2360 Cr 0.0000 Cr 24.1580 Cr
2023-03-31 -422.4520 Cr 430.3300 Cr -18.3730 Cr -463.3980 Cr -10.4980 Cr 39.8520 Cr -40.9460 Cr 12.8000 Cr -14.7740 Cr 0.0000 Cr 10.6300 Cr
2022-03-31 -108.4480 Cr 1,282.5730 Cr -1,175.8540 Cr -120.9580 Cr -1.7290 Cr 50.3500 Cr -12.5100 Cr 1,448.8080 Cr -786.0680 Cr 0.0000 Cr -38.5800 Cr
2021-03-31 106.6500 Cr -47.6790 Cr -47.1100 Cr 85.0010 Cr 11.8610 Cr 52.0790 Cr -21.7630 Cr -145.0300 Cr 52.2860 Cr 0.0000 Cr -26.4450 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 165.19 Cr 116.91 Cr 48.28 Cr 0.2923 3.29 Cr 3.98 Cr 0.65 11.74 Cr 0.0241
2025-09-30 141.13 Cr 58.94 Cr 82.19 Cr 0.5824 -26.13 Cr -13.92 Cr -2.27 -8.69 Cr -0.0986
2025-06-30 166.70 Cr 77.22 Cr 89.48 Cr 0.5368 -9.57 Cr 4.05 Cr 0.66 15.81 Cr 0.0243
2025-03-31 132.53 Cr 52.08 Cr 80.45 Cr 0.6070 -35.30 Cr -1.89 Cr -0.31 9.42 Cr -0.0143
2024-12-31 163.49 Cr 62.55 Cr 100.94 Cr 0.6174 -1.02 Cr 4.52 Cr 0.74 14.35 Cr 0.0276

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 63.67 Cr 64.68 Cr 128.35 Cr 79.19 Cr 195.33 Cr 532.98 Cr 642.68 Cr 1,254.50 Cr 432.44 Cr
2025-06-30 0.00 Cr 0.00 Cr 110.12 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -830.62 Cr
2025-03-31 82.13 Cr 88.88 Cr 179.12 Cr 75.13 Cr 213.67 Cr 545.18 Cr 636.90 Cr 1,289.75 Cr 459.13 Cr
2024-12-31 0.00 Cr 0.00 Cr 177.45 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -828.92 Cr
2024-09-30 47.67 Cr 154.77 Cr 202.44 Cr 67.08 Cr 166.82 Cr 503.77 Cr 630.08 Cr 1,243.08 Cr 414.16 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 4.05 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 -1.89 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 4.52 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 4.80 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 -15.80 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2003-02-03 February 03, 03 10:1

Similar Stocks: Biotechnology

Company Name Symbol Price Market Cap Volume
Biocon Limited BIOCON ₹395.85 ₹502,400,431,478.00 ₹3,958,795.00
Anthem Biosciences Ltd. ANTHEM ₹704.10 ₹395,502,722,489.00 ₹355,793.00
Piramal Pharma Limited PPLPHARMA ₹161.06 ₹213,141,551,189.00 ₹1,291,793.00
Syngene International Limited SYNGENE ₹433.60 ₹174,199,573,542.00 ₹1,063,178.00
Onesource Specialty Pharma Ltd. ONESOURCE ₹1,292.80 ₹148,182,287,360.00 ₹112,142.00
Concord Biotech Limited CONCORDBIO ₹1,230.90 ₹128,772,085,504.00 ₹11,424,002.00
Jubilant Ingrevia Limited JUBLINGREA ₹593.30 ₹93,747,858,071.00 ₹117,147.00
Blue Jet Healthcare Limited BLUEJET ₹399.75 ₹69,342,803,644.00 ₹1,270,572.00
Supriya Lifescience Limited SUPRIYA ₹665.20 ₹53,537,158,560.00 ₹65,822.00
Zota Health Care Limited ZOTA ₹1,214.80 ₹36,848,109,294.00 ₹83,147.00
Dishman Carbogen Amcis Limited DCAL ₹175.53 ₹27,520,136,665.00 ₹195,704.00

Key Executives

Chief Scientific Officer
Khalid Al Syed

Gender: Not Specified

Year Born: 1975

Vice President of NPI & Project Management
Naveen Kumar Jain

Gender: Not Specified

Year Born: 1972

Chairman of the Board & MD
Rajesh Jain

Gender: Not Specified

Year Born: 1964

Director Technical & Compliances and Whole -Time Director
Sanjay Trehan

Gender: Not Specified

Year Born: 1959

Whole - Time Director
Ankesh Jain

Gender: male

Year Born: 1988

Whole - Time Director
Harshet Jain

Gender: male

Year Born:

Chief Financial Officer & Head of Information Technology
Devender Gupta

Gender: male

Year Born: 1973

Senior Vice President of Sales
Gurinder Pal Singh

Gender: male

Year Born: 1967

Joint MD & Executive Director
Sandeep Jain

Gender: male

Year Born: 1966

Group Chief Financial Officer, Head of Legal, Company Secretary & Compliance Officer
Vinod Goel

Gender: male

Year Born: 1965

FAQs about Panacea Biotec Limited

Who is the CEO of the company?

The CEO is Rajesh Jain.

What is the current market price of the stock?

The current price is ₹340.15.

What is the 52-week price range?

The range is ₹281.1-581.9.

What is the market capitalization of the company?

The market capitalization is ₹2,083.44 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -267.79.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Panacea Biotec Limited (ISIN: INE922B01023) is a leading Biotechnology in India. With a market capitalization of ₹2,083.44 crores and an average daily volume of 1,103,323 shares, it operates in the Biotechnology. The company last declared a dividend of ₹0.